About Neumarker
Neumarker Inc. develops an AI-powered brain biomarker discovery platform for precision neuromedicine, using EEG measurements combined with machine learning to identify predictive and diagnostic biomarkers for central nervous system disorders such as depression, anxiety, bipolar disorder, schizophrenia, and epilepsy. The company serves CNS drug developers, mental health clinicians, and academic researchers, aiming to personalize treatment and improve the efficiency of clinical trials.
Company details
Funding
Last stage
Seed
Investors
Founders
Qiang Li
Chief Technology Officer of Neumarker Inc., presented research on EEG-based machine learning biomarkers for CNS clinical trials.
Ken Wang
Seasoned entrepreneur with 20 years of startup experience across semiconductor chip design, sensor technologies, and medical device development.
LinkedInRandy Thurman
Veteran life sciences CEO, turnaround expert, and private equity executive; former USAF fighter pilot; led integrations of major pharmaceutical companies and multiple NYSE spin-offs and IPOs.
Mike Gibbs
Strategic business leader with 30 years of experience in the biopharmaceutical industry, having held leadership roles at Sanofi (formerly Aventis) and AstraZeneca, including Vice President of Global Marketing.
What happens next.
No applications, no recruiter spam. Just the intro.
Confirm the fit
A few questions to make sure this role is the right shape for you. Two minutes.
I pitch you to the company
I write the intro, send it to the founder, and handle the back-and-forth.
A meeting lands on your calendar
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.